CD 1530 structure
|
Common Name | CD 1530 | ||
---|---|---|---|---|
CAS Number | 107430-66-0 | Molecular Weight | 398.49400 | |
Density | 1.29g/cm3 | Boiling Point | 610.7ºC at 760 mmHg | |
Molecular Formula | C27H26O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 337.2ºC |
Use of CD 1530CD1530 is a selective RARγ agonist with an Kd of 150 nM[1]. CD1530 has been used in combination with bexarotene to inhibit oral carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide in a mouse model of human oral-cavity and esophageal squamous-cell carcinoma[2]. |
Name | 4-[7-(1-adamantyl)-6-hydroxynaphthalen-2-yl]benzoic acid |
---|---|
Synonym | More Synonyms |
Description | CD1530 is a selective RARγ agonist with an Kd of 150 nM[1]. CD1530 has been used in combination with bexarotene to inhibit oral carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide in a mouse model of human oral-cavity and esophageal squamous-cell carcinoma[2]. |
---|---|
Related Catalog | |
Target |
RARγ:150 nM (Kd) |
References |
Density | 1.29g/cm3 |
---|---|
Boiling Point | 610.7ºC at 760 mmHg |
Molecular Formula | C27H26O3 |
Molecular Weight | 398.49400 |
Flash Point | 337.2ºC |
Exact Mass | 398.18800 |
PSA | 57.53000 |
LogP | 6.37840 |
Vapour Pressure | 9.03E-16mmHg at 25°C |
Index of Refraction | 1.688 |
cd 1530 |